Melinta Therapeutics, Inc., is committed to addressing the growing threat of antimicrobial resistance (AMR) by promoting the responsible and sustainable use of its antibiotics. We support innovative research initiatives and education programs that advance medical care, foster an increased understanding of scientific, clinical, and healthcare issues that improve patient outcomes, contribute to the enhancement of patient care, and otherwise offer a broad public benefit. All requests shall be reviewed by Melinta Therapeutics for consideration. Melinta Therapeutics does not guarantee the availability of funds or approval of any grant request. Please complete the appropriate forms below and submit for consideration to: grants@melinta.com
Post Approval Research & Development Grant Form